—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Pacific Biosciences of California (PACB) — Technical state

As of 2026-09-25 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

Recovery attempt under the 200-day

Trades +20.7% vs the 50-day and +2.8% vs the 200-day average, 40.7% below the 52-week high and +51.4% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the PACB chart & overview · the signal board

FAQ · from the current data · as of 2026-09-25

Quick answers

What is the current Closelooknet signal on PACB?

Recovery attempt under the 200-day — Trades +20.7% vs the 50-day and +2.8% vs the 200-day average, 40.7% below the 52-week high and +51.4% off the 52-week low. Computed from daily closes. As of 2026-09-25; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is PACB above its 50-day and 200-day moving averages?

As of 2026-09-25, Pacific Biosciences of California trades +20.7% above its 50-day and +2.8% above its 200-day average, with the 20-day +18.2% away.

How far is PACB from its 52-week high?

40.7% below the 52-week high and 51.4% above the 52-week low, as of 2026-09-25.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.